Emergency Management of Severe Constipation in Parkinson's Disease
In the emergency department, immediately order polyethylene glycol (PEG) 1 capful (17g) in 8 oz water twice daily, bisacodyl 10-15 mg orally, and perform a digital rectal exam to rule out fecal impaction—if impacted, perform manual disimpaction with pre-medication (analgesic ± anxiolytic) followed by tap water enemas until clear. 1
Immediate Assessment and Exclusion of Complications
First, rule out bowel obstruction through physical examination and abdominal x-ray 1. Two weeks without stooling in a Parkinson's patient represents a medical urgency requiring aggressive intervention. Check for:
- Fecal impaction (digital rectal exam is mandatory)
- Mechanical obstruction (abdominal distension, absent bowel sounds, vomiting)
- Metabolic causes (hypercalcemia, hypokalemia, hypothyroidism) 1
If diarrhea accompanies the constipation complaint, suspect overflow around impaction 1.
Stepwise Emergency Treatment Protocol
If Fecal Impaction is Present:
- Pre-medicate with analgesic ± anxiolytic
- Manual disimpaction 1
- Glycerin suppository ± mineral oil retention enema 1
- Tap water enema until clear 1
- Consider bisacodyl suppository (one rectally daily-BID) 1
If No Impaction:
Initiate aggressive oral bowel regimen immediately:
- Polyethylene glycol (PEG): 1 capful (17g) in 8 oz water twice daily 1, 2, 1—this is the first-line osmotic laxative with strong evidence in Parkinson's disease 3
- Bisacodyl: 10-15 mg orally daily to three times daily 1—stimulant laxatives are safe for chronic use despite common misconceptions 4, 5
Alternative or additional agents if initial therapy insufficient:
- Lactulose: 30-60 mL BID-QID 1
- Sorbitol: 30 mL every 2 hours × 3, then as needed 1
- Magnesium hydroxide: 30-60 mL daily-BID 1
- Magnesium citrate: 8 oz daily (for rapid evacuation) 2, 1
Parkinson's Disease-Specific Considerations
Critical pitfall: Parkinson's patients have impaired colonic motility and often pelvic floor dyssynergia, making constipation particularly severe and refractory 6, 7, 8. The autonomic dysfunction in PD means standard doses may be insufficient 3.
Evidence from PD-specific trials:
- Macrogol (PEG) demonstrated significant efficacy in a randomized controlled trial of 57 PD patients, improving stool frequency and consistency over 8 weeks 3
- Lubiprostone shows moderate evidence for PD-associated constipation 6, 7
- Avoid docusate sodium—it has no proven benefit and should not be used 9, 4
Medications to Review and Discontinue
Assess and discontinue any non-essential constipating medications 1:
- Anticholinergics (commonly used in PD but worsen constipation)
- Opioids (if being used for pain)
- Iron supplements
- Calcium channel blockers
Prokinetic Consideration
Metoclopramide 10-20 mg PO four times daily may be considered as a prokinetic agent 1, though use cautiously in PD as it can worsen motor symptoms through dopamine antagonism. This is a clinical judgment call in the emergency setting.
What NOT to Order
- Avoid fiber supplementation (psyllium, bran) in acute severe constipation—it can worsen obstruction without adequate fluid intake 9
- Avoid docusate sodium—no evidence of benefit 9, 4
- Avoid sodium phosphate enemas in elderly or those with renal dysfunction—risk of electrolyte abnormalities and acute phosphate nephropathy 9, 1
Disposition and Follow-up Orders
Goal: Achieve one non-forced bowel movement within 24-48 hours 1.
Discharge instructions should include:
- Continue PEG 17g twice daily indefinitely
- Maintain adequate fluid intake (at least 1.5-2 L daily)
- Follow-up with neurology within 1 week for chronic constipation management
- Consider outpatient trial of lubiprostone or prucalopride if refractory 6, 7, 10
Red flags requiring admission:
- Inability to tolerate oral intake
- Signs of bowel obstruction
- Severe abdominal pain
- Hemodynamic instability
- Failed outpatient disimpaction
The combination of osmotic laxatives (PEG) and stimulant laxatives (bisacodyl) addresses both the slow colonic transit and impaired rectal evacuation common in Parkinson's disease 2, 3. This aggressive approach is justified given the two-week duration and the known severity of constipation in PD patients.